Regional Market Reach Tridem Pharma has an established distribution footprint across nearly 90% of Africa and operates in the Middle East, presenting a broad regional entry point for partner products and potential exclusive distribution deals.

Strategic Ownership As a subsidiary of Fosun Pharma since 2017, Tridem benefits from backing, credibility, and potential access to broader product portfolios, regulatory support, and upstream/downstream resources to accelerate market expansion.

Comprehensive Services The company offers a full-market access solution including medical promotion, regulatory affairs, pharmacovigilance, and distribution of drugs, dermo-cosmetics, and IVD/rapid tests, enabling end-to-end partnerships with manufacturers seeking African and Middle Eastern penetration.

Quality and Compliance Operating under Good Pharmaceutical Distribution Practices, Tridem emphasizes high-quality logistics and regulatory compliance, reducing risk for suppliers entering complex markets with varied authorities and wholesalers.

Financial Footprint With reported revenue in the mid tens of millions and a robust regional network, there is opportunity for collaborative pilots, tiered pricing, or volume-based deals to scale sales of pharmaceutical and diagnostic products in target regions.